STAT Plus: Pelosi’s drug pricing plan could wipe out some key funding for low-income hospitals
WASHINGTON — A 60-word provision tucked into Nancy Pelosi’s signature drug pricing plan could wreak havoc on hospitals that serve the poor.
The provision deals with a federal drug discount program known as 340B that lets some hospitals and clinics buy medicines at a deep discount. When they’re reimbursed for the drugs at a higher price by Medicare or other insurers, they pocket the difference to help cover charity care, counseling services, and other costs.